Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex [ChIP-seq]

ABSTRACT: Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex [ChIP-seq]

PROVIDER: PRJNA850450 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19738201.fastq.gz	Fastqsanger.gz
	SRR19738202.fastq.gz	Fastqsanger.gz
	SRR19738203.fastq.gz	Fastqsanger.gz
	SRR19738204.fastq.gz	Fastqsanger.gz
	SRR19738205.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex

Project description:Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex

| PRJNA850446 | ENA

Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex [RNA-seq]

Project description:Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex [RNA-seq]

| PRJNA850451 | ENA

Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-12-31 | GSE206408 | GEO

Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex [RNA-seq]

Project description:To identify how DHFR deficiency affects neurogenesis by modulating neocortical gene expression at E12.5.

2022-12-31 | GSE206406 | GEO

Dihydrofolate reductase metabolic activity controls neurogenic transitions in the developing human and mouse neocortex [ChIP-seq]

Project description:To identify whether DHFR deficiency affects neurogenesis by modulating H3K4me3 methylation marks.

2022-12-31 | GSE206407 | GEO

Foxp1 developing neocortex

Project description:Foxp1 developing neocortex

| PRJNA1112378 | ENA

Primate-expressed EPIREGULIN promotes basal progenitor proliferation in the developing neocortex

Project description:Neocortex expansion during evolution is linked to higher numbers of neurons thought to result from increased proliferative capacity and neurogenic potential of basal progenitors during development. Here, we show that EREG, encoding the growth factor EPIREGULIN, is expressed in the human developing neocortex, but not in the mouse neocortex. Addition of EPIREGULIN to the mouse neocortex increases proliferation of both major basal progenitor types, intermediate basal progenitors and basal radial glia, whereas ablation of EPIREGULIN in human cortical organoids reduces basal progenitor proliferation. Here, we analyzed gene expression changes upon addition of EPIREGULIN to the mouse neocortex for 24 hours using hemisphere rotation culture. We performed fluorescent activated cell sorting to isolate radial glia (RG), intermediate progenitor (IP) cells and neurons (N) based on the nuclear markers Sox2 and Tbr2, and expression of GFP in neurons isolated from a Tubb3::GFP mouse reporter line.

2024-02-19 | GSE228007 | GEO

Extracellular matrix-inducing Sox9 orchestrates basal progenitor proliferation and gliogenesis in developing neocortex

Project description:Neocortex expansion is largely based on the proliferative capacity of basal progenitors (BPs), which is increased by extracellular matrix (ECM) components via integrin signaling. Here we show that Sox9 drives expression of ECM components and that laminin 211 increases BP proliferation in embryonic mouse neocortex. Examination of Sox9 expression reveals that Sox9 is expressed in BPs of developing ferret and human, but not mouse neocortex. Functional studies by conditional Sox9 expression in the mouse BP lineage demonstrate increased BP proliferation, reduced Tbr2 and induction of Olig2 expression, indicative of premature gliogenesis. Conditional Sox9 expression also results in cell non-autonomous stimulation of BP proliferation followed by increased production of upper-layer neurons. Collectively, our findings demonstrate that Sox9 exerts concerted effects on transcription, BP proliferation, neuron production, and neurogenic as well as gliogenic BP cell fate, suggesting that Sox9 acts a master regulator in the subventricular zone to promote neocortical expansion.

2020-03-27 | GSE134162 | GEO

Foxp1 developing neocortex (scATAC-Seq)

Project description:Foxp1 developing neocortex (scATAC-Seq)

| PRJNA1112381 | ENA

Foxp1 developing neocortex (snRNA-Seq)

Project description:Foxp1 developing neocortex (snRNA-Seq)

| PRJNA1112386 | ENA